Your browser doesn't support javascript.
loading
Gain-of-function human UNC93B1 variants cause systemic lupus erythematosus and chilblain lupus.
David, Clémence; Arango-Franco, Carlos A; Badonyi, Mihaly; Fouchet, Julien; Rice, Gillian I; Didry-Barca, Blaise; Maisonneuve, Lucie; Seabra, Luis; Kechiche, Robin; Masson, Cécile; Cobat, Aurélie; Abel, Laurent; Talouarn, Estelle; Béziat, Vivien; Deswarte, Caroline; Livingstone, Katie; Paul, Carle; Malik, Gulshan; Ross, Alison; Adam, Jane; Walsh, Jo; Kumar, Sathish; Bonnet, Damien; Bodemer, Christine; Bader-Meunier, Brigitte; Marsh, Joseph A; Casanova, Jean-Laurent; Crow, Yanick J; Manoury, Bénédicte; Frémond, Marie-Louise; Bohlen, Jonathan; Lepelley, Alice.
Affiliation
  • David C; Laboratory of Neurogenetics and Neuroinflammation, Imagine Institute, INSERM UMR1163, Paris, France.
  • Arango-Franco CA; Laboratory of Human Genetics of Infectious Diseases, INSERM UMR1163, Necker Hospital for Sick Children, Paris, France.
  • Badonyi M; Department of Microbiology and Parasitology, Group of Primary Immunodeficiencies, School of Medicine, University of Antioquia, Medellín, Colombia.
  • Fouchet J; MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh , Edinburgh, UK.
  • Rice GI; Faculté de Médecine Necker, Institut Necker Enfants Malades, INSERM U1151-CNRS UMR 8253, Université Paris Cité, Paris, France.
  • Didry-Barca B; Faculty of Biology, Medicine and Health, Division of Evolution and Genomic Sciences, School of Biological Sciences, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
  • Maisonneuve L; Laboratory of Neurogenetics and Neuroinflammation, Imagine Institute, INSERM UMR1163, Paris, France.
  • Seabra L; Faculté de Médecine Necker, Institut Necker Enfants Malades, INSERM U1151-CNRS UMR 8253, Université Paris Cité, Paris, France.
  • Kechiche R; Laboratory of Neurogenetics and Neuroinflammation, Imagine Institute, INSERM UMR1163, Paris, France.
  • Masson C; Laboratory of Neurogenetics and Neuroinflammation, Imagine Institute, INSERM UMR1163, Paris, France.
  • Cobat A; Department of Paediatric Hematology-Immunology and Rheumatology, Necker-Enfants Malades Hospital, Assistance publique-hôpitaux de Paris (AP-HP), Paris, France.
  • Abel L; Bioinformatics Core Facility, Université Paris Cité-Structure Fédérative de Recherche Necker, INSERM US24/CNRS UMS3633, Paris, France.
  • Talouarn E; Laboratory of Human Genetics of Infectious Diseases, INSERM UMR1163, Necker Hospital for Sick Children, Paris, France.
  • Béziat V; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
  • Deswarte C; Imagine Institute, Université Paris Cité , Paris, France.
  • Livingstone K; Laboratory of Human Genetics of Infectious Diseases, INSERM UMR1163, Necker Hospital for Sick Children, Paris, France.
  • Paul C; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
  • Malik G; Imagine Institute, Université Paris Cité , Paris, France.
  • Ross A; Laboratory of Human Genetics of Infectious Diseases, INSERM UMR1163, Necker Hospital for Sick Children, Paris, France.
  • Adam J; Imagine Institute, Université Paris Cité , Paris, France.
  • Walsh J; Laboratory of Human Genetics of Infectious Diseases, INSERM UMR1163, Necker Hospital for Sick Children, Paris, France.
  • Kumar S; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
  • Bonnet D; Imagine Institute, Université Paris Cité , Paris, France.
  • Bodemer C; Laboratory of Human Genetics of Infectious Diseases, INSERM UMR1163, Necker Hospital for Sick Children, Paris, France.
  • Bader-Meunier B; Imagine Institute, Université Paris Cité , Paris, France.
  • Marsh JA; MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh , Edinburgh, UK.
  • Casanova JL; Université Toulouse Paul Sabatier , Toulouse, France.
  • Crow YJ; Paediatric Rheumatology, Royal Aberdeen Children's Hospital, Aberdeen, UK.
  • Manoury B; Paediatric Rheumatology, Royal Aberdeen Children's Hospital, Aberdeen, UK.
  • Frémond ML; Paediatric Rheumatology, Royal Aberdeen Children's Hospital, Aberdeen, UK.
  • Bohlen J; Department of Paediatric Rheumatology, Royal Hospital for Children, Glasgow, UK.
  • Lepelley A; Department of Pediatrics, Pediatric Rheumatology, Christian Medical College, Vellore, India.
J Exp Med ; 221(8)2024 Aug 05.
Article de En | MEDLINE | ID: mdl-38869500
ABSTRACT
UNC93B1 is a transmembrane domain protein mediating the signaling of endosomal Toll-like receptors (TLRs). We report five families harboring rare missense substitutions (I317M, G325C, L330R, R466S, and R525P) in UNC93B1 causing systemic lupus erythematosus (SLE) or chilblain lupus (CBL) as either autosomal dominant or autosomal recessive traits. As for a D34A mutation causing murine lupus, we recorded a gain of TLR7 and, to a lesser extent, TLR8 activity with the I317M (in vitro) and G325C (in vitro and ex vivo) variants in the context of SLE. Contrastingly, in three families segregating CBL, the L330R, R466S, and R525P variants were isomorphic with respect to TLR7 activity in vitro and, for R525P, ex vivo. Rather, these variants demonstrated a gain of TLR8 activity. We observed enhanced interaction of the G325C, L330R, and R466S variants with TLR8, but not the R525P substitution, indicating different disease mechanisms. Overall, these observations suggest that UNC93B1 mutations cause monogenic SLE or CBL due to differentially enhanced TLR7 and TLR8 signaling.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Érythème pernio / Récepteur de type Toll-7 / Lupus érythémateux disséminé Limites: Adult / Child / Child, preschool / Female / Humans / Male Langue: En Journal: J Exp Med Année: 2024 Type de document: Article Pays d'affiliation: France

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Érythème pernio / Récepteur de type Toll-7 / Lupus érythémateux disséminé Limites: Adult / Child / Child, preschool / Female / Humans / Male Langue: En Journal: J Exp Med Année: 2024 Type de document: Article Pays d'affiliation: France
...